Vivos Therapeutics (VVOS) Net Margin (2020 - 2026)
Vivos Therapeutics' (VVOS) quarterly Net Margin came in at 106.37% in Q2 2026, up 2487.0% year-over-year from 4.11% in Q2 2025, and up 28.82% quarter-over-quarter from 149.43% in Q1 2026.
Powered by 
Analysis
Vivos Therapeutics (VVOS) Net Margin (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Net Margin for 7 consecutive years, with 106.37% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Margin rose 2487.0% year-over-year to 106.37% in Q2 2026; TTM through Jun 2026 was 122.09%, a 2220.0% decrease from a year earlier, with the FY2025 full-year figure at 121.71%, down 4724.0% from the prior year.
- Net Margin was 106.37% for Q2 2026 at Vivos Therapeutics, up from 149.43% in the prior quarter.
- Over five years, Net Margin peaked at 44.15% in Q1 2023 and troughed at 181.85% in Q4 2025.
- A 5-year average of 115.47% and a median of 128.05% in 2022 frame the typical range for Net Margin.
- Across the five-year window, Net Margin jumped 11522 bps in 2024 and slumped 10384 bps in 2025, its largest moves.
- Over 5 years, Net Margin stood at 154.15% in 2022, then rose by 14 bps to 132.45% in 2023, then surged by 41 bps to 78.02% in 2024, then plunged by 133 bps to 181.85% in 2025, then surged by 42 bps to 106.37% in 2026.
- The last three Net Margin figures came in at 106.37% (Q2 2026), 149.43% (Q1 2026), and 181.85% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 10.72 Bn | 9.62 Bn | 757.43 Mn | 10.25% |
| 2 | Envista Holdings | 4.23 Bn | 3.10 Bn | 407.00 Mn | 7.35% |
| 3 | Dentsply Sirona | 2.11 Bn | 1.87 Bn | 493.00 Mn | 4.01% |
| 4 | Milestone Scientific | 35.01 Mn | 32.40 Mn | 1.56 Mn | -38.85% |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | - |
| 6 | Vivos Therapeutics | 3.19 Mn | 1.39 Mn | 2.95 Mn | -106.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -106.37% |
| Mar 31, 2026 | -149.43% |
| Dec 31, 2025 | -181.85% |
| Sep 30, 2025 | -79.61% |
| Jun 30, 2025 | -131.23% |
| Mar 31, 2025 | -128.12% |
| Dec 31, 2024 | -78.02% |
| Sep 30, 2024 | -67.77% |
| Jun 30, 2024 | -47.61% |
| Mar 31, 2024 | -110.06% |
| Dec 31, 2023 | -132.45% |
| Sep 30, 2023 | -63.41% |
| Jun 30, 2023 | -162.83% |
| Mar 31, 2023 | -44.15% |
| Dec 31, 2022 | -154.15% |
| Sep 30, 2022 | -127.98% |
| Jun 30, 2022 | -167.11% |
| Mar 31, 2022 | -146.30% |
| Dec 31, 2021 | -168.25% |
| Sep 30, 2021 | -119.95% |